目次

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Workflow
1.2.2. Therapeutics Area
1.2.3. Drug type
1.2.4. Service Type
1.2.5. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Drug Discovery Outsourcing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing R&D In Biopharmaceutical Industry
3.2.1.2. Increasing demand for outsourcing Services in Drug Development
3.2.1.3. Increasing number of partnerships in drug discovery research
3.2.1.4. Technological advancements in drug discovery
3.2.1.5. Rising incidence rate of metabolic, genetic, and other chronic diseases
3.2.2. Market Restraint Analysis
3.2.2.1. Presence of open-source software packages for drug discovery
3.2.2.2. High manufacturing costs coupled with high risk of drug failure
3.3. Drug Discovery Outsourcing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis

Chapter 4. Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis
4.1. Drug Discovery Outsourcing Market, By Workflow: Segment Dashboard
4.2. Drug Discovery Outsourcing Market, By Workflow: Movement Analysis
4.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By Workflow, 2018 - 2030
4.4. Target Identification & Screening
4.4.1. Target Identification & Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Target Validation & Functional Informatics
4.5.1. Target Validation & Functional Informatics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Lead Identification & Candidate Optimization
4.6.1. Lead Identification & Candidate Optimization Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Preclinical Development
4.7.1. Preclinical Development Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Other Associate Workflow
4.8.1. Other Associate Workflow Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Drug Discovery Outsourcing Market: Therapeutics Area Estimates & Trend Analysis
5.1. Drug Discovery Outsourcing Market, By Therapeutics Area: Segment Dashboard
5.2. Drug Discovery Outsourcing Market, By Therapeutics Area: Movement Analysis
5.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By Therapeutics, 2018 - 2030
5.4. Respiratory System
5.4.1. Respiratory System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Pain and Anesthesia
5.5.1. Pain and Anesthesia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Oncology
5.6.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Ophthalmology
5.7.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Hematology
5.8.1. Hematology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Cardiovascular
5.9.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Endocrine
5.10.1. Endocrine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.11. Gastrointestinal
5.11.1. Gastrointestinal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.12. Immunomodulation
5.12.1. Immunomodulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.13. Anti-Infective
5.13.1. Anti-Infective Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.14. Central Nervous System
5.14.1. Central Nervous System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.15. Dermatology
5.15.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.16. Genitourinary System
5.16.1. Genitourinary System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Drug Discovery Outsourcing Market: Drug Type Estimates & Trend Analysis
6.1. Drug Discovery Outsourcing Market, By Drug Type: Segment Dashboard
6.2. Drug Discovery Outsourcing Market, By Drug Type: Movement Analysis
6.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By Drug Type, 2018 - 2030
6.4. Small Molecules
6.4.1. Small Molecules Market, 2018 to 2030, (USD Million)
6.5. Large Molecules (Biopharmaceuticals)
6.5.1. Large Molecules (Biopharmaceuticals) Market, 2018 to 2030, (USD Million)

Chapter 7. Drug Discovery Outsourcing Market: Service Type Estimates & Trend Analysis
7.1. Drug Discovery Outsourcing Market, By Service Type: Segment Dashboard
7.2. Drug Discovery Outsourcing Market, By Service Type: Movement Analysis
7.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By Service Type, 2018 - 2030
7.4. Chemistry Services
7.4.1. Chemistry Services Market, 2018 to 2030, (USD Million)
7.5. Biology Services
7.5.1. Biology Services Market, 2018 to 2030, (USD Million)

Chapter 8. Drug Discovery Outsourcing Market: End Use Estimates & Trend Analysis
8.1. Drug Discovery Outsourcing Market, By End Use: Segment Dashboard
8.2. Drug Discovery Outsourcing Market, By End Use: Movement Analysis
8.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By End Use, 2018 - 2030
8.4. Pharmaceutical & Biotechnology companies
8.4.1. Pharmaceutical & Biotechnology Companies Market, 2018 to 2030, (USD Million)
8.5. Academic Institutes
8.5.1. Academic Institutes Market, 2018 to 2030, (USD Million)

Chapter 9. Drug Discovery Outsourcing Market: Regional Estimates & Trend Analysis
9.1. Regional Market Share Analysis, 2024 & 2030
9.2. Regional Market Dashboard
9.3. Global Regional Market Snapshot
9.4. North America
9.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.2. U.S
9.4.2.1. Key Country Dynamics
9.4.2.2. Competitive Scenario
9.4.2.3. Regulatory Framework
9.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.3. Canada
9.4.3.1. Key Country Dynamics
9.4.3.2. Competitive Scenario
9.4.3.3. Regulatory Framework
9.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.4. Mexico
9.4.4.1. Key Country Dynamics
9.4.4.2. Competitive Scenario
9.4.4.3. Regulatory Framework
9.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Europe
9.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.2. UK
9.5.2.1. Key Country Dynamics
9.5.2.2. Competitive Scenario
9.5.2.3. Regulatory Framework
9.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.3. Germany
9.5.3.1. Key Country Dynamics
9.5.3.2. Competitive Scenario
9.5.3.3. Regulatory Framework
9.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.4. Italy
9.5.4.1. Key Country Dynamics
9.5.4.2. Competitive Scenario
9.5.4.3. Regulatory Framework
9.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.5. France
9.5.5.1. Key Country Dynamics
9.5.5.2. Competitive Scenario
9.5.5.3. Regulatory Framework
9.5.5.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.6. Spain
9.5.6.1. Key Country Dynamics
9.5.6.2. Competitive Scenario
9.5.6.3. Regulatory Framework
9.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.7. Netherland
9.5.7.1. Key Country Dynamics
9.5.7.2. Competitive Scenario
9.5.7.3. Regulatory Framework
9.5.7.4. Netherland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.8. Belgium
9.5.8.1. Key Country Dynamics
9.5.8.2. Competitive Scenario
9.5.8.3. Regulatory Framework
9.5.8.4. Belgium Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.9. Switzerland
9.5.9.1. Key Country Dynamics
9.5.9.2. Competitive Scenario
9.5.9.3. Regulatory Framework
9.5.9.4. Switzerland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.10. Russia
9.5.10.1. Key Country Dynamics
9.5.10.2. Competitive Scenario
9.5.10.3. Regulatory Framework
9.5.10.4. Russia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.11. Sweden
9.5.11.1. Key Country Dynamics
9.5.11.2. Competitive Scenario
9.5.11.3. Regulatory Framework
9.5.11.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Asia Pacific
9.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.2. China
9.6.2.1. Key Country Dynamics
9.6.2.2. Competitive Scenario
9.6.2.3. Regulatory Framework
9.6.2.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.3. Japan
9.6.3.1. Key Country Dynamics
9.6.3.2. Competitive Scenario
9.6.3.3. Regulatory Framework
9.6.3.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.4. Australia
9.6.4.1. Key Country Dynamics
9.6.4.2. Competitive Scenario
9.6.4.3. Regulatory Framework
9.6.4.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.5. South Korea
9.6.5.1. Key Country Dynamics
9.6.5.2. Competitive Scenario
9.6.5.3. Regulatory Framework
9.6.5.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.6. India
9.6.6.1. Key Country Dynamics
9.6.6.2. Competitive Scenario
9.6.6.3. Regulatory Framework
9.6.6.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.7. Thailand
9.6.7.1. Key Country Dynamics
9.6.7.2. Competitive Scenario
9.6.7.3. Regulatory Framework
9.6.7.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.8. Malaysia
9.6.8.1. Key Country Dynamics
9.6.8.2. Competitive Scenario
9.6.8.3. Regulatory Framework
9.6.8.4. Malaysia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.9. Indonesia
9.6.9.1. Key Country Dynamics
9.6.9.2. Competitive Scenario
9.6.9.3. Regulatory Framework
9.6.9.4. Indonesia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.10. Singapore
9.6.10.1. Key Country Dynamics
9.6.10.2. Competitive Scenario
9.6.10.3. Regulatory Framework
9.6.10.4. Singapore Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.11. Philippines
9.6.11.1. Key Country Dynamics
9.6.11.2. Competitive Scenario
9.6.11.3. Regulatory Framework
9.6.11.4. Philippines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.7. Latin America
9.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.7.2. Brazil
9.7.2.1. Key Country Dynamics
9.7.2.2. Competitive Scenario
9.7.2.3. Regulatory Framework
9.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.7.3. Argentina
9.7.3.1. Key Country Dynamics
9.7.3.2. Competitive Scenario
9.7.3.3. Regulatory Framework
9.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.7.4. Colombia
9.7.4.1. Key Country Dynamics
9.7.4.2. Competitive Scenario
9.7.4.3. Regulatory Framework
9.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.7.5. Chile
9.7.5.1. Key Country Dynamics
9.7.5.2. Competitive Scenario
9.7.5.3. Regulatory Framework
9.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.8. MEA
9.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.8.2. South Africa
9.8.2.1. Key Country Dynamics
9.8.2.2. Competitive Scenario
9.8.2.3. Regulatory Framework
9.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.8.3. Saudi Arabia
9.8.3.1. Key Country Dynamics
9.8.3.2. Competitive Scenario
9.8.3.3. Regulatory Framework
9.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.8.4. UAE
9.8.4.1. Key Country Dynamics
9.8.4.2. Competitive Scenario
9.8.4.3. Regulatory Framework
9.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.8.5. Kuwait
9.8.5.1. Key Country Dynamics
9.8.5.2. Competitive Scenario
9.8.5.3. Regulatory Framework
9.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.8.6. Israel
9.8.6.1. Key Country Dynamics
9.8.6.2. Competitive Scenario
9.8.6.3. Regulatory Framework
9.8.6.4. Israel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.8.7. Egypt
9.8.7.1. Key Country Dynamics
9.8.7.2. Competitive Scenario
9.8.7.3. Regulatory Framework
9.8.7.4. Egypt Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape
10.1. Market Participant Categorization
10.2. Company Market Share Analysis, 2024
10.3. Company Profiles
10.3.1. Albany Molecular Research Inc.
10.3.1.1. Company Overview
10.3.1.2. Financial Performance
10.3.1.3. Service Benchmarking
10.3.1.4. Strategic Initiatives
10.3.2. EVOTEC
10.3.2.1. Company Overview
10.3.2.2. Financial Performance
10.3.2.3. Service Benchmarking
10.3.2.4. Strategic Initiatives
10.3.3. Laboratory Corporation of America Holdings
10.3.3.1. Company Overview
10.3.3.2. Financial Performance
10.3.3.3. Service Benchmarking
10.3.3.4. Strategic Initiatives
10.3.4. GenScript
10.3.4.1. Company Overview
10.3.4.2. Financial Performance
10.3.4.3. Service Benchmarking
10.3.4.4. Strategic Initiatives
10.3.5. Pharmaceutical Product Development, LLC
10.3.5.1. Company Overview
10.3.5.2. Financial Performance
10.3.5.3. Service Benchmarking
10.3.5.4. Strategic Initiatives
10.3.6. Charles River Laboratories
10.3.6.1. Company Overview
10.3.6.2. Financial Performance
10.3.6.3. Service Benchmarking
10.3.6.4. Strategic Initiatives
10.3.7. WuXi AppTec
10.3.7.1. Company Overview
10.3.7.2. Financial Performance
10.3.7.3. Service Benchmarking
10.3.7.4. Strategic Initiatives
10.3.8. Merck & Co., Inc.
10.3.8.1. Company Overview
10.3.8.2. Financial Performance
10.3.8.3. Service Benchmarking
10.3.8.4. Strategic Initiatives
10.3.9. Thermo Fisher Scientific Inc
10.3.9.1. Company Overview
10.3.9.2. Financial Performance
10.3.9.3. Service Benchmarking
10.3.9.4. Strategic Initiatives
10.3.10. Dalton Pharma Services
10.3.10.1. Company Overview
10.3.10.2. Financial Performance
10.3.10.3. Service Benchmarking
10.3.10.4. Strategic Initiatives
10.3.11. Oncodesign
10.3.11.1. Company Overview
10.3.11.2. Financial Performance
10.3.11.3. Service Benchmarking
10.3.11.4. Strategic Initiatives
10.3.12. Jubilant Biosys
10.3.12.1. Company Overview
10.3.12.2. Financial Performance
10.3.12.3. Service Benchmarking
10.3.12.4. Strategic Initiatives
10.3.13. DiscoverX Corp.
10.3.13.1. Company Overview
10.3.13.2. Financial Performance
10.3.13.3. Service Benchmarking
10.3.13.4. Strategic Initiatives
10.3.14. QIAGEN
10.3.14.1. Company Overview
10.3.14.2. Financial Performance
10.3.14.3. Service Benchmarking
10.3.14.4. Strategic Initiatives
10.3.15. Eurofins SE
10.3.15.1. Company Overview
10.3.15.2. Financial Performance
10.3.15.3. Service Benchmarking
10.3.15.4. Strategic Initiatives
10.3.16. Syngene International Limited
10.3.16.1. Company Overview
10.3.16.2. Financial Performance
10.3.16.3. Service Benchmarking
10.3.16.4. Strategic Initiatives
10.3.17. Dr. Reddy Laboratories Ltd.
10.3.17.1. Company Overview
10.3.17.2. Financial Performance
10.3.17.3. Service Benchmarking
10.3.17.4. Strategic Initiatives
10.3.18. Pharmaron Beijing Co., Ltd.
10.3.18.1. Company Overview
10.3.18.2. Financial Performance
10.3.18.3. Service Benchmarking
10.3.18.4. Strategic Initiatives
10.3.19. TCG Lifesciences Pvt Ltd.
10.3.19.1. Company Overview
10.3.19.2. Financial Performance
10.3.19.3. Service Benchmarking
10.3.19.4. Strategic Initiatives
10.3.20. Domainex Ltd.
10.3.20.1. Company Overview
10.3.20.2. Financial Performance
10.3.20.3. Service Benchmarking
10.3.20.4. Strategic Initiatives

List of Tables
Table. 1 List of Secondary Sources
Table. 2 List of Abbreviations
Table. 3 Global Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 4 Global Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 5 Global Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 6 Global Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 7 Global Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 8 North America Discovery Outsourcing, by Country, 2018 - 2030 (USD Million)
Table. 9 North America Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 10 North America Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 11 North America Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 12 North America Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 13 North America Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 14 U.S. Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 15 U.S. Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 16 U.S. Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 17 U.S. Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 18 U.S. Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 19 Canada Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 20 Canada Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 21 Canada Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 22 Canada Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 23 Canada Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 24 Mexico Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 25 Mexico Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 26 Mexico Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 27 Mexico Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 28 Mexico Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 29 Europe Discovery Outsourcing, by Country, 2018 - 2030 (USD Million)
Table. 30 Europe Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 31 Europe Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 32 Europe Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 33 Europe Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 34 Europe Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 35 Germany Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 36 Germany Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 37 Germany Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 38 Germany Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 39 Germany Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 40 UK Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 41 UK Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 42 UK Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 43 UK Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 44 UK Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 45 France Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 46 France Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 47 France Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 48 France Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 49 France Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 50 Italy Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 51 Italy Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 52 Italy Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 53 Italy Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 54 Italy Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 55 Spain Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 56 Spain Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 57 Spain Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 58 Spain Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 59 Spain Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 60 Netherland Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 61 Netherland Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 62 Netherland Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 63 Netherland Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 64 Netherland Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 65 Belgium Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 66 Belgium Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 67 Belgium Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 68 Belgium Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 69 Belgium Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 70 Switzerland Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 71 Switzerland Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 72 Switzerland Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 73 Switzerland Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 74 Switzerland Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 75 Russia Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 76 Russia Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 77 Russia Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 78 Russia Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 79 Russia Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 80 Sweden Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 81 Sweden Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 82 Sweden Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 83 Sweden Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 84 Sweden Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 85 Asia Pacific Discovery Outsourcing, by Country, 2018 - 2030 (USD Million)
Table. 86 Asia Pacific Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 87 Asia Pacific Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 88 Asia Pacific Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 89 Asia Pacific Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 90 Asia Pacific Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 91 Japan Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 92 Japan Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 93 Japan Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 94 Japan Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 95 Japan Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 96 China Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 97 China Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 98 China Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 99 China Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 100 China Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 101 India Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 102 India Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 103 India Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 104 India Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 105 India Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 106 Thailand Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 107 Thailand Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 108 Thailand Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 109 Thailand Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 110 Thailand Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 111 South Korea Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 112 South Korea Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 113 South Korea Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 114 South Korea Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 115 South Korea Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 116 Australia Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 117 Australia Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 118 Australia Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 119 Australia Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 120 Australia Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 121 Malaysia Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 122 Malaysia Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 123 Malaysia Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 124 Malaysia Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 125 Malaysia Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 126 Indonesia Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 127 Indonesia Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 128 Indonesia Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 129 Indonesia Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 130 Indonesia Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 131 Singapore Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 132 Singapore Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 133 Singapore Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 134 Singapore Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 135 Singapore Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 136 Philippines Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 137 Philippines Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 138 Philippines Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 139 Philippines Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 140 Philippines Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 141 Latin America Discovery Outsourcing, by Country, 2018 - 2030 (USD Million)
Table. 142 Latin America Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 143 Latin America Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 144 Latin America Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 145 Latin America Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 146 Latin America Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 147 Brazil Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 148 Brazil Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 149 Brazil Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 150 Brazil Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 151 Brazil Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 152 Argentina Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 153 Argentina Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 154 Argentina Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 155 Argentina Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 156 Argentina Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 157 Colombia Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 158 Colombia Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 159 Colombia Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 160 Colombia Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 161 Colombia Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 162 Chile Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 163 Chile Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 164 Chile Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 165 Chile Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 166 Chile Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 167 Middle East & Africa Discovery Outsourcing, by Country, 2018 - 2030 (USD Million)
Table. 168 Middle East & Africa Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 169 Middle East & Africa Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 170 Middle East & Africa Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 171 Middle East & Africa Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 172 Middle East & Africa Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 173 South Africa Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 174 South Africa Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 175 South Africa Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 176 South Africa Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 177 South Africa Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 178 Saudi Arabia Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 179 Saudi Arabia Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 180 Saudi Arabia Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 181 Saudi Arabia Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 182 Saudi Arabia Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 183 UAE Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 184 UAE Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 185 UAE Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 186 UAE Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 187 UAE Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 188 Israel Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 189 Israel Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 190 Israel Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 191 Israel Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 192 Israel Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 193 Egypt Drug Discovery Outsourcing, by Workflow, 2018 - 2030 (USD Million)
Table. 194 Egypt Drug Discovery Outsourcing, by Therapeutics Area, 2018 - 2030 (USD Million)
Table. 195 Egypt Drug Discovery Outsourcing, by Drug Type, 2018 - 2030 (USD Million)
Table. 196 Egypt Drug Discovery Outsourcing, by Service Type, 2018 - 2030 (USD Million)
Table. 197 Egypt Drug Discovery Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table. 198 Regulations for pharmaceutical Workflows and Drug Types in the U.S.
Table. 199 Financial performance

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model sizing & forecasting
Fig. 9 Bottom-up approach
Fig. 10 Market snapshot
Fig. 11 Segment snapshot 1
Fig. 12 Segment snapshot 2
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook, 2024 (USD Billion)
Fig. 15 Ancillary market outlook, 2024 (USD Billion)
Fig. 16 Drug discovery outsourcing market dynamics
Fig. 17 Porter’s five forces analysis
Fig. 18 PESTEL analysis
Fig. 19 Drug Discovery Outsourcing market: Workflow outlook and key takeaways
Fig. 20 Clinical Trial Biorepository & Archiving Solutions market: Workflow movement analysis
Fig. 21 Target Identification & Screening market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Target Validation & Functional Informatics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Lead Identification & Candidate Optimization market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Preclinical Development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Other Associated Workflow market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Drug Discovery Outsourcing market: Therapeutics Area outlook and key takeaways
Fig. 27 Clinical Trial Biorepository & Archiving Solutions market: Therapeutics Area movement analysis
Fig. 28 Respiratory system market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Pain and Anesthesia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Ophthalmology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Cardiovascular market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Endocrine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Gastrointestinal market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Immunomodulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Anti-infective market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Central Nervous System market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Dermatology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Genitourinary System market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Drug Discovery Outsourcing market: Drug Type outlook and key takeaways
Fig. 42 Clinical Trial Biorepository & Archiving Solutions market: Drug Type movement analysis
Fig. 43 Small Molecules market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Large Molecules (Biopharmaceuticals) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Drug Discovery Outsourcing market: Service Type outlook and key takeaways
Fig. 46 Clinical Trial Biorepository & Archiving Solutions market: Service Type movement analysis
Fig. 47 Chemistry Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Biology Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Drug Discovery Outsourcing market: End Use outlook and key takeaways
Fig. 50 Clinical Trial Biorepository & Archiving Solutions market: End Use movement analysis
Fig. 51 Academic Institutes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Regional Marketplace: Key Takeaways
Fig. 53 North America drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 U.S. drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 Canada drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 Mexico drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Europe drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 UK drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Germany drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 France drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Italy drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Spain drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 Netherland outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 Belgium outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Switzerland outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 Russia outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Sweden outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Denmark drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 Asia Pacific drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Japan drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 China drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 India drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 Thailand drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 South Korea drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 Australia drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Key country dynamics
Fig. 98 Malaysia drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 99 Key country dynamics
Fig. 100 Indonesia drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 101 Key country dynamics
Fig. 102 Singapore drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 103 Key country dynamics
Fig. 104 Philippines drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 105 Latin America drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 106 Key country dynamics
Fig. 107 Brazil drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 108 Key country dynamics
Fig. 109 Argentina drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 110 Key country dynamics
Fig. 111 Colombia drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 112 Key country dynamics
Fig. 113 Chile drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 114 MEA drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 115 Key country dynamics
Fig. 116 South Africa drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 117 Fig. Key country dynamics
Fig. 118 Saudi Arabia drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 119 Key country dynamics
Fig. 120 UAE drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 121 Key country dynamics
Fig. 122 Israel drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 123 Key country dynamics
Fig. 124 Egypt drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 125 Key country dynamics
Fig. 126 Kuwait drug discovery outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 127 Key company categorization
Fig. 128 Service heat map analysis
Fig. 129 Strategic framework